Home page  |  About this library  |  Help  |  Clear       English  |  French  |  Spanish  
Expand Document
Expand Chapter
Full TOC
to previous section to next section

close this bookRespuesta de la Salud Pública a las Armas Biológicas y Químicas - Guía de la WHO - Segunda Edición (OPS; 2003; 302 paginas) [EN] [RU] View the PDF document
View the documentPrefacio a la edición en español
View the documentPrólogo
View the documentAgradecimientos
View the documentResumen ejecutivo
View the documentAbreviaturas y acrónimos
View the documentLista de colaboradores
open this folder and view contents1. Introducción
open this folder and view contents2. Evaluación de la amenaza a la salud pública
open this folder and view contents3. Agentes biológicos y químicos
open this folder and view contents4. Preparación y respuesta en salud pública
open this folder and view contents5. Aspectos legales
open this folder and view contents6. Fuentes internacionales de asistencia
open this folder and view contentsAnexo 1: Agentes químicos
open this folder and view contentsAnexo 2: Toxinas
open this folder and view contentsAnexo 3: Agentes biológicos
open this folder and view contentsAnexo 4: Principios de protección
open this folder and view contentsAnexo 5: Precauciones contra el sabotaje de agua potable, alimentos y otros productos
close this folderAnexo 6: Fuentes de información
View the document1. Textos principales y fuentes generales
close this folder2. Fuentes de tareas específicas
View the document2.1 Identificación del riesgo
open this folder and view contents2.2 Evaluación y manejo
close this folder2.3 Reducción y control
View the document2.3.1 Biológico
View the document2.3.2 Químico
View the document3. Sitios web que hospedan fuentes
View the documentAnexo 7: Afiliación de los estados miembro de la OMS a los tratados internacionales sobre armas químicas y biológicas
View the documentCubierta Posterior
2.3.1 Biológico

Barbera J et al. Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. Journal of the American Medical Association, 2001, 286:2711 - 2717.

Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerging Infectious Diseases, 2002, 8:833 - 841 (disponible en http://www.cdc.gov/ncidod/EID/vol8no8/pdf/01-0516.pdf

Cieslak TJ et al. Immunization against potential biological warfare agents. Clinical Infectious Diseases, 2000, 30:843 - 850.

Guidance document on the use of medicinal products for the treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism. London, European Agency for the Evaluation of Medicinal Products, 2002 (document CPMP/4048/01; disponible en http://www.emea.eu.int/pdfs/human/bioterror/404801.pdf

Richard P et al. Guide to infection control in the hospital: an official publication of the International Society for Infectious Diseases. Hamilton, ON, BC Decker, 1988.

Treatment of biological warfare agent casualties. Field Manual 8-284, NAVMED P-5042, Air Force Manual (Interservice) 44-156, Marine Corps MCRP 4-11.1C, Headquarters, Departments of the Army, the Navy, and the Air Force, and Commandant Marine Corps, Washington, DC, 17 July 2000.

to previous section to next section

Please provide your feedback   English  |  French  |  Spanish